Quetiapine Fumarate XR Tablets

SOL #: SPE2D223D0012Award Notice

Overview

Buyer

DEPT OF DEFENSE
Defense Logistics Agency
DLA TROOP SUPPORT
PHILADELPHIA, PA, 19111, United States

Place of Performance

Hauppauge, NY

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

Drugs And Biologicals (6505)

Set Aside

No set aside specified

Timeline

1
Posted
Sep 7, 2023
2
Last Updated
Sep 26, 2024

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Modification SPE2D223D0012 P00001 to incorporate Drug Supply Chain Security Act language into solicitation for subject contract. 

Award SPE2D223D0012 Quetiapine Fumarate XR Tablets 

People

Points of Contact

Phyllis DaraioPRIMARY

Files

Files

Download
Download

Versions

Version 4
Award Notice
Posted: Sep 26, 2024
View
Version 3
Award Notice
Posted: Sep 19, 2023
View
Version 2Viewing
Award Notice
Posted: Sep 8, 2023
Version 1
Award Notice
Posted: Sep 7, 2023
View
Quetiapine Fumarate XR Tablets | GovScope